Exploring the Fungi – in Your Garden and Beyond
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Further Studies on Psilocybe from the Caribbean, Central America and South America, with Descriptions of New Species and Remarks to New Records
ZOBODAT - www.zobodat.at Zoologisch-Botanische Datenbank/Zoological-Botanical Database Digitale Literatur/Digital Literature Zeitschrift/Journal: Sydowia Jahr/Year: 2009 Band/Volume: 61 Autor(en)/Author(s): Guzman Gaston, Ramirez-Guillen Florencia, Horak Egon, Halling Roy Artikel/Article: Further studies on Psilocybe from the Caribbean, Central America and South America, with descriptions of new species and remarks to new records. 215-242 ©Verlag Ferdinand Berger & Söhne Ges.m.b.H., Horn, Austria, download unter www.biologiezentrum.at Further studies on Psilocybe from the Caribbean, Central America and South America, with descriptions of new species and remarks to new records. Gastón Guzmán1*, Egon Horak2, Roy Halling3, Florencia Ramírez-Guillén1 1 Instituto de Ecología, Apartado Postal 63, Xalapa 91000, Mexico. 2 Nikodemweg 5, AT-6020 Innsbruck, Austria. 3 New York Botanical Garden, New York, Bronx, NY 10458-5126, USA.leiferous Guzmán G., Horak E., Halling R. & Ramírez-Guillén F. (2009). Further studies on Psilocybe from the Caribbean, Central America and South America, with de- scriptions of new species and remarks to new records. – Sydowia 61 (2): 215–242. Seven new species of Psilocybe (P. bipleurocystidiata, P. multicellularis, P. ne- oxalapensis, P. rolfsingeri, P. subannulata, P. subovoideocystidiata and P. tenuitu- nicata are described and illustrated. Included are also discussion and remarks refer- ring to new records of the following taxa: P. egonii, P. fagicola, P. montana, P. mus- corum, P. plutonia, P. squamosa, P. subhoogshagenii, P. subzapotecorum, P. wright- ii, P. yungensis and P. zapotecoantillarum. Thirteen of the enumerated species are hallucinogenic. Key words: Basidiomycotina, Strophariaceae, Agaricales, bluing, not bluing. In spite of numerous studies on the genus Psilocybe in the Carib- bean, Central America and South America (Singer & Smith 1958; Singer 1969, 1977, 1989; Guzmán 1978, 1983, 1995; Pulido 1983, Sáenz & al. -
Boletus Mushrooms La Tia Jackson, Ian C
Genetic Diversity within Alaskan Boletus Mushrooms www.fungi-zette.com La Tia Jackson, Ian C. Herriott, József Geml, Gary A. Laursen, D. Lee Taylor Discussion Abstract •Clade 1 is composed of Alaskan samples from the interior and Northwest and We analyzed the genetic differences within the collection of samples from Europe. Although the species names do not match up they are genetically very similar, and B. citrinovirens is thought to be in what is called the Boletus mushroom from the UAF Fungal Herbarium, representing Identification on Tree Location subtomentosus group. samples from all over Alaska. Upon analyzing the DNA sequence Results DQ066405_Boletus_citrinovirens Europe from 18 samples, we found that most Alaskan Boletus are closely DQ066407_Boletus_spadiceus Europe •Clade 2 is composed of Alaskan samples from Southeast Alaska and GenBank DQ066397_Boletus_citrinovirens Europe samples from Europe, both identified as Boletus mirabilis. related to samples from the same species found in other parts of the world (clades 1,2,5,6,8,12). We also found that some species DQ066410_Boletus_spadiceus Europe •Clade 3 is composed of samples only from Alaska. None of the sequences DQ384578_Boletellus_mirabilis Europe collected in other parts of the world were not found in our sample 1 mycorance.free.fr obtained from GenBank are closely related. These were morphologically collection (clades 4,7,9,10,11). Finally, our results suggested that AJ419187_Boletus_impolitus Spain identified as B. subglabripes. “B. subglabripes” is in GenBank, but only Large 100 DQ131632_Xerocomus_subtomentosus Europe clade 3 on our phylogenetic tree is not represented among the Subunit gene, not Internally Transcribed Spacer gene (reference 2) so comparison AJ889931_Boletus_pruinatus Europe GenBank sequences from other parts of the world and may be a 100 is not possible to determine if morphological species attribution is the same or 2 AM087271_Xerocomus_pruinatus Europe genetic lineage endemic to Alaska. -
2014 Fall Spore Print [Pdf]
Fall 2014 Volume XXXX No. 3 The Newsletter of the Connecticut Valley Mycological Society Affiliate of the North American Mycological Association Member Northeastern Mycological Federation Founder: Ed Bosman President: Bill Bynum (860)214-2639 COMING EVENTS email: [email protected] Oct. 26: CVMS Tailgate! Stratton Brook State Park, Vice President: Bill Yule Simsbury, CT A regular foray at 10am followed by potluck email: [email protected] Treasurer:Terri Hungerford lunch. Please see food event guidelines in Member Handbook. email: [email protected] Important: Remember to print your dish ingredients on a card Secretary: Ellen Bulger along with your name. email: [email protected] Nov. 2: Final foray of the year: Gay City State Park, Hebron Membership Sec.: Karen Monger There will still be things to find with all the rain we've had! email: [email protected] Dec. 5–7: GSMS Winter Foray, Crawfordville, Florida The Spore Print Editor:Dinah Wells email: [email protected] GSMS (Gulf States Mycological Society) Winter Foray 2014 will be held at the Best Western Plus, Crawfordville, FL, 18 Membership: Dues per calendar year are $15 individual; $20 family (two or more persons at one address and miles south of Tallahassee. The Guest Mycologist will be Dr. requiring only one copy of club mailings). Lifetime Matthew Smith, Assistant Professor in the Department of Plant memberships are $200 individual and $250 family. Pathology and curator of the UF Fungal Herbarium, at the Make checks payable to CVMS and send to: CVMS/Karen Monger, 32A Perkins Ave., Norwich, CT University of Florida, Gainesville. Dr. Smith plans to bring a 06360. -
Field Guide to Common Macrofungi in Eastern Forests and Their Ecosystem Functions
United States Department of Field Guide to Agriculture Common Macrofungi Forest Service in Eastern Forests Northern Research Station and Their Ecosystem General Technical Report NRS-79 Functions Michael E. Ostry Neil A. Anderson Joseph G. O’Brien Cover Photos Front: Morel, Morchella esculenta. Photo by Neil A. Anderson, University of Minnesota. Back: Bear’s Head Tooth, Hericium coralloides. Photo by Michael E. Ostry, U.S. Forest Service. The Authors MICHAEL E. OSTRY, research plant pathologist, U.S. Forest Service, Northern Research Station, St. Paul, MN NEIL A. ANDERSON, professor emeritus, University of Minnesota, Department of Plant Pathology, St. Paul, MN JOSEPH G. O’BRIEN, plant pathologist, U.S. Forest Service, Forest Health Protection, St. Paul, MN Manuscript received for publication 23 April 2010 Published by: For additional copies: U.S. FOREST SERVICE U.S. Forest Service 11 CAMPUS BLVD SUITE 200 Publications Distribution NEWTOWN SQUARE PA 19073 359 Main Road Delaware, OH 43015-8640 April 2011 Fax: (740)368-0152 Visit our homepage at: http://www.nrs.fs.fed.us/ CONTENTS Introduction: About this Guide 1 Mushroom Basics 2 Aspen-Birch Ecosystem Mycorrhizal On the ground associated with tree roots Fly Agaric Amanita muscaria 8 Destroying Angel Amanita virosa, A. verna, A. bisporigera 9 The Omnipresent Laccaria Laccaria bicolor 10 Aspen Bolete Leccinum aurantiacum, L. insigne 11 Birch Bolete Leccinum scabrum 12 Saprophytic Litter and Wood Decay On wood Oyster Mushroom Pleurotus populinus (P. ostreatus) 13 Artist’s Conk Ganoderma applanatum -
The Hallucinogenic Mushrooms: Diversity, Traditions, Use and Abuse with Special Reference to the Genus Psilocybe
11 The Hallucinogenic Mushrooms: Diversity, Traditions, Use and Abuse with Special Reference to the Genus Psilocybe Gastón Guzmán Instituto de Ecologia, Km 2.5 carretera antigua a Coatepec No. 351 Congregación El Haya, Apartado postal 63, Xalapa, Veracruz 91070, Mexico E-mail: [email protected] Abstract The traditions, uses and abuses, and studies of hallucinogenic mush- rooms, mostly species of Psilocybe, are reviewed and critically analyzed. Amanita muscaria seems to be the oldest hallucinogenic mushroom used by man, although the first hallucinogenic substance, LSD, was isolated from ergot, Claviceps purpurea. Amanita muscaria is still used in North Eastern Siberia and by some North American Indians. In the past, some Mexican Indians, as well as Guatemalan Indians possibly used A. muscaria. Psilocybe has more than 150 hallucinogenic species throughout the world, but they are used in traditional ways only in Mexico and New Guinea. Some evidence suggests that a primitive tribe in the Sahara used Psilocybe in religions ceremonies centuries before Christ. New ethnomycological observations in Mexico are also described. INTRODUCTION After hallucinogenic mushrooms were discovered in Mexico in 1956-1958 by Mr. and Mrs. Wasson and Heim (Heim, 1956; Heim and Wasson, 1958; Wasson, 1957; Wasson and Wasson, 1957) and Singer and Smith (1958), a lot of attention has been devoted to them, and many publications have 257 flooded the literature (e.g. Singer, 1958a, b, 1978; Gray, 1973; Schultes, 1976; Oss and Oeric, 1976; Pollock, 1977; Ott and Bigwood, 1978; Wasson, 1980; Ammirati et al., 1985; Stamets, 1996). However, not all the fungi reported really have hallucinogenic properties, because several of them were listed by erroneous interpretation of information given by the ethnic groups originally interviewed or by the bibliography. -
FDA OTC Reviews Summary of Back Issues
Number 23 The Journal of the AMERICAN BOTANI CAL COUNCIL and the HERB RESEARCH FOUNDATION Chinese Medicinals -A Comprehensive Review of Chinese Materia Medica Legal and Regulatory- FDA OTC Reviews Summary of Back Issues Ongoing Market Report, Research Reviews (glimpses of studies published in over a dozen scientific and technical journals), Access, Book Reviews, Calendar, Legal and Regulatory, Herb Blurbs and Potpourri columns. #1 -Summer 83 (4 pp.) Eucalyptus Repels Reas, Stones Koalas; FDA OTC tiveness; Fungal Studies; More Polysaccharides; Recent Research on Ginseng; Heart Panel Reviews Menstrual & Aphrodisiac Herbs; Tabasco Toxicity?; Garlic Odor Peppers; Yew Continues to Amaze; Licorice O.D. Prevention; Ginseng in Perspec Repels Deer; and more. tive; Poisonous Plants Update; Medicinal Plant Conservation Project; 1989 Oberly #2- Fall/Winter 83-84 (8 pp.) Appeals Court Overrules FDA on Food Safety; Award Nominations; Trends in Self-Care Conference; License Plates to Fund Native FDA Magazine Pans Herbs; Beware of Bay Leaves; Tiny Tree: Cancer Cure?; Plant Manual; and more. Comfrey Tea Recall; plus. #17-Summer 88. (24 pp.) Sarsaparilla, A Literature Review by Christopher #3-Spring 84 (8 pp.) Celestial Sells to Kraft; Rowers and Dinosaurs Demise?; Hobbs; Hops May Help Metabolize Toxins; Herbal Roach Killer; Epazote Getting Citrus Peels for Kitty Litter; Saffron; Antibacterial Sassafras; WHO Studies Anti· More Popular, Aloe Market Levels Off; Herbal Tick Repellent?; Chinese Herb fertility Plants; Chinese Herbal Drugs; Feverfew Migraines; -
Cultural Characterization and Chlamydospore Function of the Ganodermataceae Present in the Eastern United States
Mycologia ISSN: 0027-5514 (Print) 1557-2536 (Online) Journal homepage: https://www.tandfonline.com/loi/umyc20 Cultural characterization and chlamydospore function of the Ganodermataceae present in the eastern United States Andrew L. Loyd, Eric R. Linder, Matthew E. Smith, Robert A. Blanchette & Jason A. Smith To cite this article: Andrew L. Loyd, Eric R. Linder, Matthew E. Smith, Robert A. Blanchette & Jason A. Smith (2019): Cultural characterization and chlamydospore function of the Ganodermataceae present in the eastern United States, Mycologia To link to this article: https://doi.org/10.1080/00275514.2018.1543509 View supplementary material Published online: 24 Jan 2019. Submit your article to this journal View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=umyc20 MYCOLOGIA https://doi.org/10.1080/00275514.2018.1543509 Cultural characterization and chlamydospore function of the Ganodermataceae present in the eastern United States Andrew L. Loyd a, Eric R. Lindera, Matthew E. Smith b, Robert A. Blanchettec, and Jason A. Smitha aSchool of Forest Resources and Conservation, University of Florida, Gainesville, Florida 32611; bDepartment of Plant Pathology, University of Florida, Gainesville, Florida 32611; cDepartment of Plant Pathology, University of Minnesota, St. Paul, Minnesota 55108 ABSTRACT ARTICLE HISTORY The cultural characteristics of fungi can provide useful information for studying the biology and Received 7 Feburary 2018 ecology of a group of closely related species, but these features are often overlooked in the order Accepted 30 October 2018 Polyporales. Optimal temperature and growth rate data can also be of utility for strain selection of KEYWORDS cultivated fungi such as reishi (i.e., laccate Ganoderma species) and potential novel management Chlamydospores; tactics (e.g., solarization) for butt rot diseases caused by Ganoderma species. -
New Species of Psilocybe from Papua New Guinea, New Caledonia and New Zealand
ZOBODAT - www.zobodat.at Zoologisch-Botanische Datenbank/Zoological-Botanical Database Digitale Literatur/Digital Literature Zeitschrift/Journal: Sydowia Jahr/Year: 1978/1979 Band/Volume: 31 Autor(en)/Author(s): Guzman Gaston, Horak Egon Artikel/Article: New Species of Psilocybe from Papua New Guinea, New Caledonia and New Zealand. 44-54 ©Verlag Ferdinand Berger & Söhne Ges.m.b.H., Horn, Austria, download unter www.biologiezentrum.at New Species of Psilocybe from Papua New Guinea, New Caledonia and New Zealand G. GUZMAN Escuela Nacional de Ciencias Biologicas, I. P. N., A. P. 26-378, Mexico 4, D. F. and E. HORAK Institut Spezielle Botanik, ETHZ, 8092 Zürich, Schweiz Zusammenfassung. Aus Auslralasien (Papua New Guinea, Neu Kaledonien und Neu Seeland) werden 6 neue Arten von Psilocybe (P. brunneo- cystidiata, P. nothofagensis, P. papuana, P. inconspicua, P. neocaledonica and P. novae-zelandiae) beschrieben. Zudem wird die systematische Stellung dieser Taxa bezüglich P. montana, P. caerulescens, P. mammillata, P. yungensis und anderer von GUZMÄN in den tropischen Wäldern von Mexiko gefundenen Psilocybe-Arten diskutiert. Between 1967 and 1977 one of the authors (HORAK) made several collections of Psilocybe in Papua New Guinea, New Caledonia and New Zealand. After studying the material it was surprising to note that all fungi collected do represent new species. This fact may indicate the high grade of endemism of the fungus flora on the Australasian Islands. Nevertheless, the new taxa described have interesting taxo- nomic relationships with species known from tropical America and temperate Eurasia. These connections are discussed in the text. Concerning Psilocybe only three records are published so far from the before mentioned Australasian region: 1. -
AMATOXIN MUSHROOM POISONING in NORTH AMERICA 2015-2016 by Michael W
VOLUME 57: 4 JULY-AUGUST 2017 www.namyco.org AMATOXIN MUSHROOM POISONING IN NORTH AMERICA 2015-2016 By Michael W. Beug: Chair, NAMA Toxicology Committee Assessing the degree of amatoxin mushroom poisoning in North America is very challenging. Understanding the potential for various treatment practices is even more daunting. Although I have been studying mushroom poisoning for 45 years now, my own views on potential best treatment practices are still evolving. While my training in enzyme kinetics helps me understand the literature about amatoxin poisoning treatments, my lack of medical training limits me. Fortunately, critical comments from six different medical doctors have been incorporated in this article. All six, each concerned about different aspects in early drafts, returned me to the peer reviewed scientific literature for additional reading. There remains no known specific antidote for amatoxin poisoning. There have not been any gold standard double-blind placebo controlled studies. There never can be. When dealing with a potentially deadly poisoning (where in many non-western countries the amatoxin fatality rate exceeds 50%) treating of half of all poisoning patients with a placebo would be unethical. Using amatoxins on large animals to test new treatments (theoretically a great alternative) has ethical constraints on the experimental design that would most likely obscure the answers researchers sought. We must thus make our best judgement based on analysis of past cases. Although that number is now large enough that we can make some good assumptions, differences of interpretation will continue. Nonetheless, we may be on the cusp of reaching some agreement. Towards that end, I have contacted several Poison Centers and NAMA will be working with the Centers for Disease Control (CDC). -
Effect of Ganoderma Lucidum (Reishi) on Hematological Parameters
Available online at www.ijmrhs.com cal R edi ese M ar of c l h a & n r H u e o a J l l t h International Journal of Medical Research & a S n ISSN No: 2319-5886 o c i t i Health Sciences, 2018, 7(3): 151-157 e a n n c r e e t s n I • • IJ M R H S Effect of Ganoderma lucidum (Reishi) on Hematological Parameters in Wistar Rats Hammad Ahmed and Muhammad Aslam* Department of Pharmacology, Faculty of Pharmacy, Ziauddin University, Karachi, Pakistan *Corresponding e-mail: [email protected] ABSTRACT Ganoderma lucidum (Reishi), has been used in Traditional Chinese Medicine (TCM) for 5000 years or more. In China and Japan Ganoderma lucidum has been used in folk medicine, commonly in the treatment of neurasthenia, insomnia, hepatopathy, nephritis, gastric ulcers, asthma, and hypertension. In this study we have evaluated the effect of Ganoderma lucidum on hematological parameters in Wistar rats. The extract was given orally by gavage at the dose of 150 mg/kg and 300 mg/kg body weight. The result of our study shows extremely significant increase in the hemoglobin level, platelet count and leukocyte count more specifically at a dose of 150 mg/kg of Ganoderma lucidum extract when compare with normal control group. However, at a dose of 300 mg/kg of GLE, significant increase in hemoglobin level and extremely significant increase in leukocyte count were observed. Whereas, insignificant result was observed at both the doses of GLE in case of hematocrit level, MCV, MCHC, MCH and RBC count. -
Psilocybin Mushrooms Fact Sheet
Psilocybin Mushrooms Fact Sheet January 2017 What are psilocybin, or “magic,” mushrooms? For the next two decades thousands of doses of psilocybin were administered in clinical experiments. Psilocybin is the main ingredient found in several types Psychiatrists, scientists and mental health of psychoactive mushrooms, making it perhaps the professionals considered psychedelics like psilocybin i best-known naturally-occurring psychedelic drug. to be promising treatments as an aid to therapy for a Although psilocybin is considered active at doses broad range of psychiatric diagnoses, including around 3-4 mg, a common dose used in clinical alcoholism, schizophrenia, autism spectrum disorders, ii,iii,iv research settings ranges from 14-30 mg. Its obsessive-compulsive disorder, and depression.xiii effects on the brain are attributed to its active Many more people were also introduced to psilocybin metabolite, psilocin. Psilocybin is most commonly mushrooms and other psychedelics as part of various found in wild or homegrown mushrooms and sold religious or spiritual practices, for mental and either fresh or dried. The most popular species of emotional exploration, or to enhance wellness and psilocybin mushrooms is Psilocybe cubensis, which is creativity.xiv usually taken orally either by eating dried caps and stems or steeped in hot water and drunk as a tea, with Despite this long history and ongoing research into its v a common dose around 1-2.5 grams. therapeutic and medical benefits,xv since 1970 psilocybin and psilocin have been listed in Schedule I of the Controlled Substances Act, the most heavily Scientists and mental health professionals criminalized category for drugs considered to have a consider psychedelics like psilocybin to be “high potential for abuse” and no currently accepted promising treatments as an aid to therapy for a medical use – though when it comes to psilocybin broad range of psychiatric diagnoses. -
Forest Fungi in Ireland
FOREST FUNGI IN IRELAND PAUL DOWDING and LOUIS SMITH COFORD, National Council for Forest Research and Development Arena House Arena Road Sandyford Dublin 18 Ireland Tel: + 353 1 2130725 Fax: + 353 1 2130611 © COFORD 2008 First published in 2008 by COFORD, National Council for Forest Research and Development, Dublin, Ireland. All rights reserved. No part of this publication may be reproduced, or stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying recording or otherwise, without prior permission in writing from COFORD. All photographs and illustrations are the copyright of the authors unless otherwise indicated. ISBN 1 902696 62 X Title: Forest fungi in Ireland. Authors: Paul Dowding and Louis Smith Citation: Dowding, P. and Smith, L. 2008. Forest fungi in Ireland. COFORD, Dublin. The views and opinions expressed in this publication belong to the authors alone and do not necessarily reflect those of COFORD. i CONTENTS Foreword..................................................................................................................v Réamhfhocal...........................................................................................................vi Preface ....................................................................................................................vii Réamhrá................................................................................................................viii Acknowledgements...............................................................................................ix